Vine Ventures

Lykos Therapeutics aims to transform mental health treatment by developing innovative medicines and therapies assisted by psychedelics. With over three decades of experience, they focus on rigorous scientific research to create novel therapeutic options.

SpaceVision leverages AI to analyze offline customer engagement, offering targeted marketing strategies for advertisers and retailers.

TRIPP is a digital wellness company that develops immersive experiences for virtual reality, augmented reality, and mobile devices to support emotional well-being. The platform combines mindfulness structures, sound frequencies, visuals, and interactive elements to influence mood—helping users feel calmer, more focused, and less stressed. Aimed at consumer households, TRIPP delivers these experiences through VR, AR, and mobile formats, grounded in research-based content. The company is headquartered in Los Angeles, California, with a satellite development office in Chicago.

Essor is a growth platform for consumer brands, offering branding, acquisitions, sourcing, and marketing to help brands scale from startup to omnichannel global players. It delivers digital branding services, strategic consulting, and e-commerce growth solutions, leveraging technology and partnerships to expand reach. It manages a portfolio of health and wellness and lifestyle brands that are sold on Amazon, direct-to-consumer channels, and major retailers such as Target, CVS, and Walmart.

Clerkenwell Health is a mental health company providing clinical research support services and psychedelic-assisted therapies. It operates as a psychedelic-specialist contract research organization focused on psychiatry and central nervous system conditions, delivering independent CRO services to advance the adoption of psychedelic treatments in Europe. The company runs a healthcare clinic offering preparation, treatment sessions, and follow-up by experienced psychotherapists, and it collaborates to produce robust, clinically validated data sets that demonstrate the efficacy of psilocybin-assisted therapy relative to existing standards of care. By centering patients in trial design and therapy protocols, Clerkenwell Health aims to improve outcomes while supporting rigorous evaluation of novel psychedelic interventions.

Span Health Limited, founded in 2018 and based in London, is a digital care provider focused on improving health outcomes through innovative technology. The company offers a mobile application that facilitates health and fitness tracking, enabling users to monitor their health data and reverse conditions such as diabetes, hyperinsulinemia, and other lifestyle-induced diseases. Span's services include support from healthcare professionals, such as doctors and nutritionists, to guide users in making informed dietary choices that enhance metabolic health and alleviate symptoms associated with conditions like polycystic ovary syndrome, fatty liver disease, and irritable bowel syndrome. By combining technology with personalized care, Span aims to help individuals reduce body fat, manage blood sugar levels, and improve overall well-being.